Clinical Trial Update: An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia

View source ↗

Summary

An observational study assesses infusion-related adverse events during MabThera (rituximab) administration in patients with chronic lymphocytic leukemia. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Status: COMPLETED